UBS’s iPath Inverse S&P 500 VIX Short-Term Futures IVOP Stock Holding History

UBS’s Portfolio IVOP Stock Details IVOP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$49K	Buy	1,290 +4	+0.3%	+$153	﹤0.01%	6870
2014 Q2	$49K	Hold	1,286	–	–	﹤0.01%	6904
2014 Q1	$49K	Buy	1,286 +100	+8%	+$3.8K	﹤0.01%	6877
2013 Q4	$45K	Hold	1,186	–	–	﹤0.01%	7114
2013 Q3	$45K	Sell	1,186 -100	-8%	-$3.75K	﹤0.01%	7027
2013 Q2	$47K	Buy	+1,286	New	+$47.8K	﹤0.01%	6824

Other funds holding IVOP

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS's IVOP Position: Q3 2014 in Review

UBS increased its iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) stake by 0.31% in Q3 2014, buying an estimated $153 and bringing the position to 1,290 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #6870.

UBS first reported a position in IVOP in Q2 2013 and has held it in 6 quarters since. 3 funds tracked by Wall St. Rank hold IVOP as of Q3 2014.

UBS held 1,290 shares of iPath Inverse S&P 500 VIX Short-Term Futures worth $49K as of Q3 2014.
UBS bought 4 iPath Inverse S&P 500 VIX Short-Term Futures shares in Q3 2014, an estimated $153.
iPath Inverse S&P 500 VIX Short-Term Futures made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6870 holding.
UBS first reported a position in iPath Inverse S&P 500 VIX Short-Term Futures in Q2 2013 and has held it in 6 quarters since.
3 funds tracked by Wall St. Rank held iPath Inverse S&P 500 VIX Short-Term Futures as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.